Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Smart Diabetes Management Market: By Product: Smart Glucose Meters, Continuous Glucose Monitoring Systems, Smart Insulin Pens, Smart Insulin Pumps, Closed Loop Systems; By Application; By End Use; Regional Analysis; Historical Market and Forecast (2017-2027); Competitive Landscape; Industry Events and Developments
Global Smart Diabetes Management Market Outlook
The global smart diabetes management market attained a value of USD 4 billion in 2020. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 14.75% to reach USD 9.2 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America is the leading market in the industry. The smart diabetes management market in the region is being driven by the high presence of key players who have a diversified product portfolio and the early adoption of technologically advanced treatment techniques. With a growing towards among the patients for the self-management of the disease, the market in the region is being further propelled forward. The Asia Pacific and Europe are also significant markets in the industry due to the rising population of the patients afflicted with diabetes in the regions.
Properties and Applications
Smart diabetes management help to manage diabetes by increasing patient compliance and helping an individual maintain their blood glucose levels, which is an essential component for controlling diabetes. It contains devices that are integrated with mobile applications via Bluetooth or USB and includes devices like blood glucose monitoring and insulin delivery devices.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on products, the smart diabetes management market can be divided into:
- Smart Glucose Meters
- Continuous Glucose Monitoring Systems
- Smart Insulin Pens
- Smart Insulin Pumps
- Closed Loop Systems
The market can be broadly categorised based on its applications segments as:
- Type 1 Diabetes
- Type 2 Diabetes
Based on its end-use segments, the industry can be divided as:
- Home Healthcare
- Hospitals
- Specialty Diabetes Clinics
The EMR report looks into the regional markets of smart diabetes management like the Asia Pacific, the Middle East and Africa, Europe, Latin America, and North America.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The market is being driven by the rising prevalence of diabetes and a growing demand for self-diabetes management. The rising innovation and product diversification in the industry is expected to drive the market in the coming years. The increasing demand for smart glucose level monitoring and insulin devices, which are integrated with digital health solutions, is expected to catalyse the industry growth the further. The growing trend of healthcare IT and connected healthcare is expected to propel the industry further forward.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global smart diabetes management market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- F. Hoffmann-La Roche Ltd
- Medtronic PLC (NYSE: MDT)
- Dexcom, Inc
- Insulet Corporation
- Ascensia Diabetes Care Holdings AG
- LifeScan, Inc.
- Glooko, Inc.
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Application, End Use, Region |
| Breakup by Product | Smart Glucose Meters, Continuous Glucose Monitoring Systems, Smart Insulin Pens, Smart Insulin Pumps, Closed Loop Systems |
| Breakup by Application | Type 1 Diabetes, Type 2 Diabetes |
| Breakup by End Use | Home Healthcare, Hospitals, Specialty Diabetes Clinics |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | F. Hoffmann-La Roche Ltd, Medtronic PLC (NYSE: MDT), Dexcom, Inc (NASDAQ: DXCM), Insulet Corporation (NASDAQ: PODD), Ascensia Diabetes Care Holdings AG, LifeScan, Inc., Glooko, Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
1.1 Objectives of the Study
1.1.1 Research Objective
1.1.2 Key Findings of the Report
2 Research Methodology
2.1 Data Extraction
2.2 Data Corroboration
2.3 Market Structure
2.4 Assumptions
2.5 Market Models
3 Introduction
3.1 Market Outlook
3.2 Key Industry Trends
3.3 Market Scope and Segmentation
3.4 Additional Insights
4 Executive Summary
4.1 Key Market Developments
4.2 Market Analysis
4.3 Key Players
4.4 Market Revenue and Growth
5 Market Dynamics
5.1 Market Driver Analysis
5.2 Market Restraint Analysis
5.3 Industry Challenges
5.4 Industry Opportunities
6 Global Smart Diabetes Management Market Analysis
6.1 Global Smart Diabetes Management Historical Market (2017-2021) & Forecast (2022-2027)
6.2 Global Smart Diabetes Management Market Breakup by Product
6.2.1 Smart Glucose Meters
6.2.2 Continuous Glucose Monitoring Systems
6.2.3 Smart Insulin Pens
6.2.4 Smart Insulin Pumps
6.2.5 Closed Loop Systems
6.3 Global Smart Diabetes Management Market Breakup by Product: Historical Market (2017-2021) & Forecast (2022-2027)
6.3.1 Smart Glucose Meters
6.3.2 Continuous Glucose Monitoring Systems
6.3.3 Smart Insulin Pens
6.3.4 Smart Insulin Pumps
6.3.5 Closed Loop Systems
6.4 Global Smart Diabetes Management Market Breakup by Application
6.4.1 Type 1 Diabetes
6.4.2 Type 2 Diabetes
6.5 Global Smart Diabetes Management Market Breakup by Application: Historical Market (2017-2021) & Forecast (2022-2027)
6.5.1 Type 1 Diabetes
6.5.2 Type 2 Diabetes
6.6 Global Smart Diabetes Management Market Breakup by End Use
6.6.1 Home Healthcare
6.6.2 Hospitals
6.6.3 Specialty Diabetes Clinics
6.7 Global Smart Diabetes Management Market Breakup by End Use: Historical Market (2017-2021) & Forecast (2022-2027)
6.7.1 Home Healthcare
6.7.2 Hospitals
6.7.3 Specialty Diabetes Clinics
6.8 Global Smart Diabetes Management Market Breakup by Region
6.8.1 North America
6.8.1.1 United States of America
6.8.1.2 Canada
6.8.2 Europe
6.8.2.1 Germany
6.8.2.2 United Kingdom
6.8.2.3 France
6.8.2.4 Italy
6.8.2.5 Others
6.8.3 Asia Pacific
6.8.3.1 China
6.8.3.2 Japan
6.8.3.3 India
6.8.3.4 ASEAN
6.8.3.5 Others
6.8.4 Latin America
6.8.4.1 Brazil
6.8.4.2 Argentina
6.8.4.3 Mexico
6.8.4.4 Others
6.8.5 Middle East & Africa
6.8.5.1 Saudi Arabia
6.8.5.2 United Arab Emirates
6.8.5.3 Nigeria
6.8.5.4 South Africa
6.8.5.5 Others
6.9 Global Smart Diabetes Management Market Breakup by Region: Historical Market (2017-2021) & Forecast (2022-2027)
6.9.1 North America
6.9.1.1 United States of America
6.9.1.2 Canada
6.9.2 Europe
6.9.2.1 Germany
6.9.2.2 United Kingdom
6.9.2.3 France
6.9.2.4 Italy
6.9.2.5 Others
6.9.3 Asia Pacific
6.9.3.1 China
6.9.3.2 Japan
6.9.3.3 India
6.9.3.4 ASEAN
6.9.3.5 Others
6.9.4 Latin America
6.9.4.1 Brazil
6.9.4.2 Argentina
6.9.4.3 Mexico
6.9.4.4 Others
6.9.5 Middle East & Africa
6.9.5.1 Saudi Arabia
6.9.5.2 United Arab Emirates
6.9.5.3 Nigeria
6.9.5.4 South Africa
6.9.5.5 Others
7 SWOT Analysis
7.1 Overview
7.2 Strengths
7.3 Weaknesses
7.4 Opportunities
7.5 Threats
8 Porter’s Five Forces Analysis
8.1 Overview
8.2 Buyer’s Power
8.3 Supplier’s Power
8.4 New Entrants
8.5 Degree of Rivalry
8.6 Substitutes
9 Value Chain Analysis
10 EMR’s Key Indicators for Demand
11 EMR’s Key Indicators for Price
12 Competitive Landscape & Supplier Analysis
12.1 F. Hoffmann-La Roche Ltd
12.1.1 Company Overview
12.1.2 Financial Analysis
12.2 Medtronic PLC (NYSE: MDT)
12.2.1 Company Overview
12.2.2 Financial Analysis
12.3 Dexcom, Inc (NASDAQ: DXCM)
12.3.1 Company Overview
12.3.2 Financial Analysis
12.4 Insulet Corporation (NASDAQ: PODD)
12.4.1 Company Overview
12.4.2 Financial Analysis
12.5 Ascensia Diabetes Care Holdings AG
12.5.1 Company Overview
12.5.2 Financial Analysis
12.6 LifeScan, Inc.
12.6.1 Company Overview
12.6.2 Financial Analysis
12.7 Glooko, Inc.
12.7.1 Company Overview
12.7.2 Financial Analysis
12.8 Others
13 Industry Events and Developments
Key Questions Answered in the Report
In 2020, the global smart diabetes management market attained a value of nearly USD 4 billion.
The market is projected to grow at a CAGR of 14.75% between 2021 and 2026.
The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach USD 9.2 billion by 2026.
The major drivers of the industry include rising prevalence of diabetes, growing demand for self-diabetes management, rising innovation, and product diversification in the industry, and increasing demand for smart glucose level monitoring and insulin devices, which are integrated with digital health solutions.
The growing trend of healthcare IT and connected healthcare is expected to be a key trend guiding the growth of the industry.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest share in the market.
The types of smart diabetes management available are smart glucose meters, continuous glucose monitoring systems, smart insulin pens, smart insulin pumps, and closed loop systems.
Smart diabetes management finds applications as type 1 diabetes and type 2 diabetes.
Smart diabetes management can have different end-uses like home healthcare, hospitals, and specialty diabetes clinics.
The leading players in this market are F. Hoffmann-La Roche Ltd, Medtronic PLC (NYSE: MDT), Dexcom, Inc, Insulet Corporation, Ascensia Diabetes Care Holdings AG, LifeScan, Inc., and Glooko, Inc., amongst others.
Analyst Review
The global smart diabetes management market attained a value of USD 4 billion in 2020, driven by the rising prevalence of diabetes, growing demand for self-diabetes management, rising innovation and product diversification in the industry and increasing demand for smart glucose level monitoring and insulin devices, which are integrated with digital health solutions. Aided by the growing trend of healthcare IT and connected healthcare, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 14.75%. The market is projected to reach USD 9.2 billion by 2026.
EMR’s meticulous research methodology delves deep into the industry, covering the macro and micro aspects of the industry. Based on the products, the smart diabetes management market can be segmented into smart glucose meters, continuous glucose monitoring systems, smart insulin pens, smart insulin pumps, and closed loop systems. By application, the industry can be divided into type 1 diabetes and type 2 diabetes. Smart diabetes management can have different end-uses like home healthcare, hospitals, and specialty diabetes clinics. The major regional markets for smart diabetes management are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the market. The key players in the above industry include F. Hoffmann-La Roche Ltd, Medtronic PLC (NYSE: MDT), Dexcom, Inc, Insulet Corporation, Ascensia Diabetes Care Holdings AG, LifeScan, Inc., and Glooko, Inc., amongst others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global disposable blood pressure cuffs market attained a value of nearly USD 252.5 million in 2021, driven by the increasing prevalence of health-related issues. Aided by the availability of dispo...
The global ventilators market attained a value of about USD 5.1 billion in 2020, driven by the COVID-19 outbreak. Aided by the growing technological advancements, the market is expected to witness a f...
The global autoinjector market attained a value of USD 1.78 billion in 2020. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 18.10% to reach USD 4.85 billion by...
The global patient monitoring market attained a value of about USD 19,200 million in 2020, driven by the robust government and private investments in patient monitoring devices. Aided by the surge in ...
The global smart medical devices market attained a value of about USD 8.3 billion in 2020, driven by robust demand for self-monitoring devices. Aided by the adoption of therapeutic devices in the home...
NEWSLETTER